Fig. 1From: High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansineKaplan-Meier PFS curves of HER2-Positive Advanced Breast Cancer Patients With T-DM1 Treatment. a Patients stratified according baseline LDH. b Patients stratified according baseline dNLR. c Patients stratified according LNIBack to article page